These findings align with studies linking reduced CB1 expression to cognitive dysfunction in Parkinson’s models and AD postmortem brain tissues [94, 95] and highlighting CB2’s role in cognitive [96] and social [97, 98] functions. This evidence concerns the gene CNR1 and Parkinson disease.